{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:41:41Z","timestamp":1792806101064,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04443-0","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:41:46Z","timestamp":1780659706000},"page":"5263-5270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stereotactic body radiation therapy (SBRT) with MRI-Linac in oligometastatic gynaecological cancer patients: a systematic review"],"prefix":"10.1007","volume":"28","author":[{"given":"Donato","family":"Pezzulla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Catucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4037-9740","authenticated-orcid":false,"given":"Martina","family":"Iezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savino","family":"Cilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Cusumano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Boldrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Preziosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Deodato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Carlo","family":"Mattiucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"2","key":"4443_CR1","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1634\/theoncologist.2019-0309","volume":"25","author":"G Macchia","year":"2020","unstructured":"Macchia G, Lazzari R, Colombo N, Laliscia C, Capelli G, D\u2019Agostino GR, et al. A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 Study): a collaboration of MITO, AIRO GYN, and MaNGO Groups. Oncologist. 2020;25(2):e311\u201320.","journal-title":"Oncologist"},{"key":"4443_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ygyno.2024.01.023","volume":"184","author":"G Macchia","year":"2024","unstructured":"Macchia G, Cilla S, Pezzulla D, Campitelli M, Laliscia C, Lazzari R, et al. Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer. Gynecol Oncol. 2024;184:16\u201323.","journal-title":"Gynecol Oncol"},{"key":"4443_CR3","doi-asserted-by":"crossref","unstructured":"Macchia G, Campitelli M, Pezzulla D, Lucci S, Fodor A, Russo D, et al. Stereotactic ablative radiation therapy for oligometastatic ovarian cancer lymph node disease: the MITO-RT3\/RAD phase II trial. Int J Radiat Oncol. 2024; S0360301624034023","DOI":"10.1136\/ijgc-2024-IGCS.29"},{"issue":"24","key":"4443_CR4","first-page":"03369","volume":"S0360\u20133016","author":"G Macchia","year":"2024","unstructured":"Macchia G, Pezzulla D, Campitelli M, Russo D, Ronzino G, Lucci S, et al. Stereotactic body radiation therapy for oligoprogressive ovarian cancer patients treated during poly(ADP-Ribose)-Polymerase inhibitor maintenance: efficacy and adverse events from the epimetheo retrospective study. Int J Radiat Oncol Biol Phys. 2024;S0360\u20133016(24):03369\u201378.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"4443_CR5","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3390\/healthcare11172413","volume":"11","author":"G Macchia","year":"2023","unstructured":"Macchia G, Titone F, Restaino S, Arcieri M, Pellecchia G, Andreetta C, et al. Is it time to reassess the role of radiotherapy treatment in ovarian cancer? Healthcare. 2023;11(17):2413.","journal-title":"Healthcare"},{"issue":"8","key":"4443_CR6","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/ijgc-2024-005361","volume":"34","author":"S Durante","year":"2024","unstructured":"Durante S, Cuccia F, Rigo M, Caminiti G, Mastroleo F, Lazzari R, et al. Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi). Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. 2024;34(8):1232\u20139.","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc."},{"issue":"3","key":"4443_CR7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ijrobp.2018.03.058","volume":"101","author":"R Lazzari","year":"2018","unstructured":"Lazzari R, Ronchi S, Gandini S, Surgo A, Volpe S, Piperno G, et al. Stereotactic body radiation therapy for oligometastatic ovarian cancer: a step toward a drug holiday. Int J Radiat Oncol. 2018;101(3):650\u201360.","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"4443_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8\u201310.","journal-title":"J Clin Oncol"},{"issue":"3","key":"4443_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ijrobp.2015.02.016","volume":"92","author":"EL Pollom","year":"2015","unstructured":"Pollom EL, Deng L, Pai RK, Brown JM, Giaccia A, Loo BW, et al. Gastrointestinal toxicities with combined antiangiogenic and stereotactic body radiation therapy. Int J Radiat Oncol. 2015;92(3):568\u201376.","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"4443_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13014-024-02445-2","volume":"19","author":"G Chiloiro","year":"2024","unstructured":"Chiloiro G, Panza G, Boldrini L, Romano A, Placidi L, Nardini M, et al. REPeated mAgnetic resonance Image-guided stereotactic body Radiotherapy (MRIg-reSBRT) for oligometastatic patients: REPAIR, a mono-institutional retrospective study. Radiat Oncol. 2024;19(1):52. https:\/\/doi.org\/10.1186\/s13014-024-02445-2.","journal-title":"Radiat Oncol"},{"issue":"1","key":"4443_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1102\/1470-7330.2006.0016","volume":"6","author":"I Barillot","year":"2006","unstructured":"Barillot I. The use of MRI in planning radiotherapy for gynaecological tumours. Cancer Imaging. 2006;6(1):100\u20136.","journal-title":"Cancer Imaging"},{"issue":"9","key":"4443_CR12","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3109\/0284186X.2015.1062541","volume":"54","author":"CE Noel","year":"2015","unstructured":"Noel CE, Parikh PJ, Spencer CR, Green OL, Hu Y, Mutic S, et al. Comparison of onboard low-field magnetic resonance imaging versus onboard computed tomography for anatomy visualization in radiotherapy. Acta Oncol. 2015;54(9):1474\u201382. https:\/\/doi.org\/10.3109\/0284186X.2015.1062541.","journal-title":"Acta Oncol"},{"key":"4443_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.radonc.2021.03.025","volume":"159","author":"S Corradini","year":"2021","unstructured":"Corradini S, Alongi F, Andratschke N, Azria D, Bohoudi O, Boldrini L, et al. ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology. Radiother Oncol. 2021;159:146\u201354. https:\/\/doi.org\/10.1016\/j.radonc.2021.03.025.","journal-title":"Radiother Oncol"},{"key":"4443_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ctro.2019.10.003","volume":"20","author":"L Boldrini","year":"2019","unstructured":"Boldrini L, Chiloiro G, Pesce A, Romano A, Teodoli S, Placidi L, et al. Hybrid MRI guided radiotherapy in locally advanced cervical cancer: case report of an innovative personalized therapeutic approach. Clin Transl Radiat Oncol. 2019;20:27\u20139. https:\/\/doi.org\/10.1016\/j.ctro.2019.10.003.","journal-title":"Clin Transl Radiat Oncol"},{"key":"4443_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2024.100808","volume":"47","author":"A Romano","year":"2024","unstructured":"Romano A, Votta C, Nardini M, Chiloiro G, Panza G, Boldrini L, et al. Uterus motion analysis for radiotherapy planning optimization. The innovative contribution of on-board hybrid MR imaging. Clin Transl Radiat Oncol. 2024;47:100808. https:\/\/doi.org\/10.1016\/j.ctro.2024.100808.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"6","key":"4443_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1177\/0300891620901752","volume":"106","author":"L Boldrini","year":"2020","unstructured":"Boldrini L, Piras A, Chiloiro G, Autorino R, Cellini F, Cusumano D, et al. Low Tesla magnetic resonance guided radiotherapy for locally advanced cervical cancer: first clinical experience. Tumori. 2020;106(6):497\u2013505. https:\/\/doi.org\/10.1177\/0300891620901752.","journal-title":"Tumori"},{"key":"4443_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.phro.2019.02.003","volume":"9","author":"D Winkel","year":"2019","unstructured":"Winkel D, Bol GH, Werensteijn-Honingh AM, Kiekebosch IH, van Asselen B, Intven MPW, et al. Evaluation of plan adaptation strategies for stereotactic radiotherapy of lymph node oligometastases using online magnetic resonance image guidance. Phys Imaging Radiat Oncol. 2019;9:58\u201364.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"4443_CR18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2422","volume-title":"A new era of image guidance with magnetic resonance-guided radiation therapy for abdominal and thoracic malignancies","author":"K Mittauer","year":"2018","unstructured":"Mittauer K, Paliwal B, Hill P, Bayouth JE, Geurts MW, Baschnagel AM, et al. A new era of image guidance with magnetic resonance-guided radiation therapy for abdominal and thoracic malignancies. Cureus; 2018."},{"issue":"3","key":"4443_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.radonc.2018.07.025","volume":"129","author":"D Cusumano","year":"2018","unstructured":"Cusumano D, Dhont J, Boldrini L, Chiloiro G, Teodoli S, Massaccesi M, et al. Predicting tumour motion during the whole radiotherapy treatment: a systematic approach for thoracic and abdominal lesions based on real time MR. Radiother Oncol. 2018;129(3):456\u201362. https:\/\/doi.org\/10.1016\/j.radonc.2018.07.025.","journal-title":"Radiother Oncol"},{"issue":"10185","key":"4443_CR20","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet Lond Engl. 2019;393(10185):2051\u20138.","journal-title":"Lancet Lond Engl."},{"issue":"18","key":"4443_CR21","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201","volume":"37","author":"DR Gomez","year":"2019","unstructured":"Gomez DR, Tang C, Zhang J, Blumenschein GR, Hernandez M, Lee JJ, et al. Local consolidative therapy vs maintenance therapy or observation for patients with oligometastatic non small cell lung cancer: long-term results of a multi-institutional, phase II, randomized Study. J Clin Oncol. 2019;37(18):1558\u201365.","journal-title":"J Clin Oncol"},{"key":"4443_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2016.00249","volume":"6","author":"S Hasan","year":"2016","unstructured":"Hasan S, Ricco A, Jenkins K, Lanciano R, Hanlon A, Lamond J, et al. Survival and control prognosticators of recurrent gynecological malignancies of the pelvis and para-aortic region treated with stereotactic body radiation therapy. Front Oncol. 2016;6:249. https:\/\/doi.org\/10.3389\/fonc.2016.00249.","journal-title":"Front Oncol"},{"key":"4443_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"4443_CR24","volume-title":"Development of a quality appraisal tool for case series studies using a modified Delphi technique","author":"C Moga","year":"2012","unstructured":"Moga C, Guo B, Schopflocher D, Harstall C. Development of a quality appraisal tool for case series studies using a modified Delphi technique. Edmonton, Alberta, Canada: Institute of Health Economics; 2012."},{"issue":"2","key":"4443_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ijrobp.2021.08.033","volume":"112","author":"LE Henke","year":"2022","unstructured":"Henke LE, Stanley JA, Robinson C, Srivastava A, Contreras JA, Curcuru A, et al. Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer. Int J Radiat Oncol febbraio. 2022;112(2):379\u201389.","journal-title":"Int J Radiat Oncol febbraio"},{"issue":"11","key":"4443_CR26","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1007\/s00432-021-03739-8","volume":"147","author":"F Cuccia","year":"2021","unstructured":"Cuccia F, Rigo M, Gurrera D, Nicosia L, Mazzola R, Figlia V, et al. Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases. J Cancer Res Clin Oncol novembre. 2021;147(11):3269\u201377.","journal-title":"J Cancer Res Clin Oncol. novembre"},{"key":"4443_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2022.107696","volume":"99","author":"G Yavas","year":"2022","unstructured":"Yavas G, Kuscu UE, Ayhan A, Yavas C, Onal C. The utility of 15 tesla MR-guided adaptive stereotactic body radiotherapy for recurrent ovarian tumor \u2013 case reports and review of the literature. Int J Surg Case Rep. 2022;99:107696.","journal-title":"Int J Surg Case Rep"},{"key":"4443_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.radonc.2020.09.020","volume":"154","author":"D Winkel","year":"2021","unstructured":"Winkel D, Werensteijn-Honingh AM, Eppinga WSC, Intven MPW, Hes J, Snoeren LMW, et al. Dosimetric feasibility of hypofractionation for SBRT treatment of lymph node oligometastases on the 1.5T MR-linac. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2021;154:243\u20138.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol."},{"issue":"4","key":"4443_CR29","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1016\/j.prro.2022.03.002","volume":"12","author":"DS Lakomy","year":"2022","unstructured":"Lakomy DS, Yang J, Vedam S, Wang J, Lee B, Sobremonte A, et al. Clinical implementation and initial experience with a 1.5 Tesla MR-Linac for MR-guided radiation therapy for gynecologic cancer an R-IDEAL Stage 1 and 2a first in humans feasibility study of new technology implementation. Pract Radiat Oncol. 2022;12(4):e296-305.","journal-title":"Pract Radiat Oncol"},{"key":"4443_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.radonc.2019.01.024","volume":"134","author":"AM Werensteijn-Honingh","year":"2019","unstructured":"Werensteijn-Honingh AM, Kroon PS, Winkel D, Aalbers EM, van Asselen B, Bol GH, et al. Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: multi-fraction treatment of pelvic lymph node oligometastases. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2019;134:50\u20134.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol."},{"key":"4443_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.radonc.2020.09.021","volume":"154","author":"AM Werensteijn-Honingh","year":"2021","unstructured":"Werensteijn-Honingh AM, J\u00fcrgenliemk-Schulz IM, Gadellaa-Van Hooijdonk CG, Sikkes GG, Vissers NGPM, Winkel D, et al. Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2021;154:110\u20137.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol."}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04443-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04443-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04443-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:02:24Z","timestamp":1792803744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04443-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["4443"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04443-0","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There is no conflict of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a systematic review based exclusively on previously published data and did not involve the direct participation of human subjects or animals. Therefore, ethical approval and informed consent were not required.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}